Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARG | P13631 | 2/20 | 0.33 |
| ▸ | RXRA | P19793 | 2/20 | 0.33 |
| ▸ | PPARG | P37231 | 2/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | CD69 | Q07108 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13368066 | 0.88 | RXRA (0.40) | RARGRXRAPPARGCYP2C19PTGS2 | |
| SCHEMBL18088898 | 0.87 | RARG (0.40) | RARGRXRAPPARGESR1ESR2 | |
| SCHEMBL14999403 | 0.85 | RARG (0.33) | RARGRXRAPPARGCYP2C19PTGS2 | |
| SCHEMBL14999487 | 0.84 | PTGS2 (0.39) | ESR1ESR2CYP2C19PTGS2HTT | |
| SCHEMBL13452244 | 0.79 | DHFR (0.41) | RXRACYP2C19PTGS2ELANECD69 | |
| SCHEMBL14999407 | 0.78 | CYP3A4 (0.37) | RARGRXRAPPARGESR1ESR2 | |
| SCHEMBL15249007 | 0.77 | PTGS2 (0.47) | CYP2C19PTGS2HTTL3MBTL1 | |
| SCHEMBL17072151 | 0.77 | ALDH1A1 (0.36) | RARGRXRAPPARGPTGS2 | |
| SCHEMBL18465079 | 0.76 | RARG (0.33) | RARGRXRAPPARG | |
| SCHEMBL14612535 | 0.76 | POLB (0.35) | CYP2C19PTGS2ELANECD69 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160272761-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2016-09-22 | — | — | US | disclosed |
| US-9403861-B2 | Salen complexes with dianionic counterions | NOVOMER, INC. (US) | 2016-08-02 | — | — | US | disclosed |
| US-9327280-B2 | Catalytic carbonylation catalysts and methods | NOVOMER, INC. (US) | 2016-05-03 | — | — | US | disclosed |
| US-20150368394-A1 | CATALYSTS AND METHODS FOR POLYESTER PRODUCTION | NOVOMER, INC. | 2015-12-24 | — | — | US | disclosed |
| US-8946109-B2 | Catalysts and methods for polymer synthesis | NOVOMER, INC. (US) | 2015-02-03 | — | — | US | disclosed |
| US-20140336354-A1 | SALEN COMPLEXES WITH DIANIONIC COUNTERIONS | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2014-11-13 | — | — | US | disclosed |
| US-20140296522-A1 | CATALYTIC CARBONYLATION CATALYSTS AND METHODS | Novomer, Inc (US) | 2014-10-02 | — | — | US | disclosed |
| US-20130144032-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | NOVOMER, INC. (US) | 2013-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140296522-A1 | CATALYTIC CARBONYLATION CATALYSTS AND METHODS | CBR3, CBR1, EPHX2 | RARG 2594/4885RXRA 3331/4885PPARG 2682/4885 |
| US-20140336354-A1 | SALEN COMPLEXES WITH DIANIONIC COUNTERIONS | NCLN, POLN, NCL | RARG 3233/4885RXRA 3363/4885PPARG 3268/4885 |
| US-20130144032-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | PPOX, COASY, SOD1 | RARG 3178/4885RXRA 2979/4885PPARG 2858/4885 |
| US-20160272761-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | PPOX, COASY, SOD1 | RARG 3178/4885RXRA 2979/4885PPARG 2858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.